# Anika Therapeutics, Inc.: Form DEF 14A, filed Apr 28, 2025

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: DEF 14A
- Filed: 2025-04-28
- Accepted by EDGAR: Apr 28, 2025, 17:26 ET
- Period: 2025-06-20
- Accession: 0001140361-25-016082
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000114036125016082/edge20045980x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000114036125016082/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000114036125016082/edge20045980x1_def14a.htm

Filed Apr 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-016082. Last ingested by Listed: Nov 6, 2026, 15:05 ET. No prices; not investment advice.
